ChemFeeds Site Navigation:
Journal Selection:
Search:

99) High-Risk Prostate Cancer Prognostic Outlier Gene Landscape (Clinical Cancer Research) Friday April 1st 2016


100) InsR/IGF1R Confers Resistance to EGFR Inhibitors (Clinical Cancer Research) Friday April 1st 2016


101) Biomarker for Early Breast Cancer Detection (Clinical Cancer Research) Friday April 1st 2016


102) hnRNPH1-AR Axis in Prostate Tumorigenesis (Clinical Cancer Research) Friday April 1st 2016


103) Reduced Serum TSP-1 Prior to Clinical Diagnosis of PDAC (Clinical Cancer Research) Friday April 1st 2016


104) A 5-Marker Blood Test for CRC Early Detection (Clinical Cancer Research) Friday April 1st 2016


105) Chronic Stress and DUSP1-Mediated Chemoresistance (Clinical Cancer Research) Friday April 1st 2016


106) mTOR Inhibitors Impair HR Repair through Suppressing SUV39H1 (Clinical Cancer Research) Friday April 1st 2016


107) TH-302 Targets Hypoxic Cells in Leukemia Models (Clinical Cancer Research) Friday April 1st 2016


108) PLK1 Inhibition in NSCLC (Clinical Cancer Research) Friday April 1st 2016


109) Nuclear Export Inhibition and Radiation in Rectal Cancer (Clinical Cancer Research) Friday April 1st 2016


110) Multigene Signatures in TNBC (Clinical Cancer Research) Friday April 1st 2016


111) Mesothelin Imaging in Pancreatic or Ovarian Cancer Patients (Clinical Cancer Research) Friday April 1st 2016


112) Monitoring Treatment Response of m-IDH Glioma by 2HG-fSM (Clinical Cancer Research) Friday April 1st 2016


113) TOP1 as a Predictive Biomarker for Irinotecan (Clinical Cancer Research) Friday April 1st 2016


114) Plasma Circulating Proteins and Bevacizumab (Clinical Cancer Research) Friday April 1st 2016


115) Early Metabolic Response in Advanced Gastric Cancer (Clinical Cancer Research) Friday April 1st 2016


116) Personalized Therapies in BRAF Inhibitor-Resistant PDX (Clinical Cancer Research) Friday April 1st 2016


117) Phase I BKM120 (Buparlisib) and Fulvestrant in Breast Cancer (Clinical Cancer Research) Friday April 1st 2016


118) Ibrutinib Disrupts CLL Tumor-Microenvironment Interactions (Clinical Cancer Research) Friday April 1st 2016


119) TREC to Where? (Clinical Cancer Research) Friday April 1st 2016


120) Gene Therapy for Epithelial Cancers (Clinical Cancer Research) Friday April 1st 2016


121) Core Patient-Reported Outcomes in Cancer Clinical Trials (Clinical Cancer Research) Friday April 1st 2016


122) PDX System for Modeling Personalized Medicine (Clinical Cancer Research) Friday April 1st 2016


123) Ibrutinib Remodels the CLL Microenvironment (Clinical Cancer Research) Friday April 1st 2016


124) Flightless I Represses Androgen Receptor (Clinical Cancer Research) Monday March 14th 2016


125) Aggressive Variant Prostate Cancers Signature (Clinical Cancer Research) Monday March 14th 2016


126) CTCs in Neuroendocrine Prostate Cancer (Clinical Cancer Research) Monday March 14th 2016


127) MEK Inhibition Cooperates with Anti-PD-L1 Therapy in TNBC (Clinical Cancer Research) Monday March 14th 2016


128) Prognostic Molecular Factors in Colorectal Cancer by Age (Clinical Cancer Research) Monday March 14th 2016


129) CXCR4 Mutation in Waldenstrom Macroglobulinemia (Clinical Cancer Research) Monday March 14th 2016


130) Effects of Pharmacokinetic Modulation of Anti-DLL4 Antibody (Clinical Cancer Research) Monday March 14th 2016


131) Combined Photodynamic Therapy-Immunotherapy against Advanced Cancer (Clinical Cancer Research) Monday March 14th 2016


132) A Novel Bioavailable BH3 Mimetic (Clinical Cancer Research) Monday March 14th 2016


133) Inhibition of Pancreatic Cancer by RhIL1RA (Clinical Cancer Research) Monday March 14th 2016


134) ERR{alpha} Is a Marker of Tamoxifen Response in TNBC (Clinical Cancer Research) Monday March 14th 2016


135) Breast Cancer Risk Variants and Radiation Toxicity (Clinical Cancer Research) Monday March 14th 2016


136) Fluorescent Image-Guided Surgery with an Anti-PSCA Diabody (Clinical Cancer Research) Monday March 14th 2016


137) Pharmacogenetic Associations of AI-Mediated Lipid Changes (Clinical Cancer Research) Monday March 14th 2016


138) A Phase I Study of Lenvatinib in Advanced HCC (Clinical Cancer Research) Monday March 14th 2016


139) Zoledronic Acid and Skeletal-Related Events in Multiple Myeloma (Clinical Cancer Research) Monday March 14th 2016


140) HLA-B*57:01 Associated with Pazopanib Hepatotoxicity (Clinical Cancer Research) Monday March 14th 2016


141) Pediatric Phase I Ipilimumab (Clinical Cancer Research) Monday March 14th 2016


142) Galeterone for Metastatic Castration-Resistant Prostate Cancer (Clinical Cancer Research) Monday March 14th 2016


143) Nesvacumab for Advanced Solid Tumors (Clinical Cancer Research) Monday March 14th 2016


144) Surrogate Endpoints in Melanoma That Correlate with OS (Clinical Cancer Research) Monday March 14th 2016


145) LAG-3Ig as Adjuvant for a Cancer Vaccine (Clinical Cancer Research) Monday March 14th 2016


146) Sonidegib in Basal Cell Carcinomas Resistant to Vismodegib (Clinical Cancer Research) Monday March 14th 2016


147) Optimal Dosing for Targeted Therapies in Oncology (Clinical Cancer Research) Monday March 14th 2016


148) AXL Expression and Acquisition of Drug Resistance (Clinical Cancer Research) Monday March 14th 2016


149) FDA Approval of Gefitinib for Metastatic EGFR-Positive NSCLC (Clinical Cancer Research) Monday March 14th 2016


150) Fluorescence-Guided Surgery for Prostate Cancer Patients (Clinical Cancer Research) Monday March 14th 2016


151) Z-MARK Trial in Myeloma (Clinical Cancer Research) Monday March 14th 2016


152) Correction: p73 Expression Is Associated with the Cellular Radiosensitivity in Cervical Cancer after Radiotherapy (Clinical Cancer Research) Tuesday March 1st 2016


153) Correction: Differential Functions of Growth Factor Receptor-Bound Protein 7 (GRB7) and Its Variant GRB7v in Ovarian Carcinogenesis (Clinical Cancer Research) Tuesday March 1st 2016


154) VEGF and VTE Risk in Cancer Patients--Letter (Clinical Cancer Research) Tuesday March 1st 2016


155) KITENIN/ErbB4-CYT-2 Promotes Adenoma to Carcinoma Transition (Clinical Cancer Research) Tuesday March 1st 2016


156) AGL-HAS2 Axis in Bladder Cancer (Clinical Cancer Research) Tuesday March 1st 2016


157) CXCL12 and Prognosis in Stage I Nonseminomas (Clinical Cancer Research) Tuesday March 1st 2016


158) Prognostic Significance of Hippo Pathway in Liver Cancer (Clinical Cancer Research) Tuesday March 1st 2016


159) Id1 Regulates E2F1 Degradation and Cancer Chemoresistance (Clinical Cancer Research) Tuesday March 1st 2016


160) PRAME as a Biomarker in Uveal Melanoma (Clinical Cancer Research) Tuesday March 1st 2016


161) LNA-i-miR-221 Inhibitor Overcomes Melphalan Resistance (Clinical Cancer Research) Tuesday March 1st 2016


162) Combined Apoptosis Induction of ATRA with Sorafenib in AML (Clinical Cancer Research) Tuesday March 1st 2016


163) Mithramycin and MPM (Clinical Cancer Research) Tuesday March 1st 2016


164) Preclinical Efficacy of RG7112 in Glioblastoma (Clinical Cancer Research) Tuesday March 1st 2016


165) Synergistic Antitumor Effect of RFA and PD-1 Blockade (Clinical Cancer Research) Tuesday March 1st 2016


166) Radiation and Vaccination Reverse Tolerance to CNS Melanoma (Clinical Cancer Research) Tuesday March 1st 2016


167) Targeting the MDM2:p53 Axis in DDLPS (Clinical Cancer Research) Tuesday March 1st 2016


168) Targeting of BCL2 Proteins in Diffuse Large B-Cell Lymphoma (Clinical Cancer Research) Tuesday March 1st 2016


169) ESR1 Mutations in Advanced Breast Cancer (Clinical Cancer Research) Tuesday March 1st 2016


170) In Vivo Detection of Succinate in Paraganglioma (Clinical Cancer Research) Tuesday March 1st 2016


171) rs966423-Related Mortality in Patients with Thyroid Cancer (Clinical Cancer Research) Tuesday March 1st 2016


172) T790M by Tumor Biopsy versus Blood-Based Analyses (Clinical Cancer Research) Tuesday March 1st 2016


173) Ralimetinib for Advanced Cancer (Clinical Cancer Research) Tuesday March 1st 2016


174) Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer (Clinical Cancer Research) Tuesday March 1st 2016


175) Metformin in Pancreatic Cancer (Clinical Cancer Research) Tuesday March 1st 2016


176) A Phase II Study of AZD6244 in Multiple Myeloma (Clinical Cancer Research) Tuesday March 1st 2016


177) Abexinostat in Mantle Cell and Follicular Lymphoma (Clinical Cancer Research) Tuesday March 1st 2016


178) New Life for Immunotoxin Cancer Therapy (Clinical Cancer Research) Tuesday March 1st 2016


179) T-VEC for Cancer (Clinical Cancer Research) Tuesday March 1st 2016


180) Classical Myeloproliferative Neoplasms: New Insights (Clinical Cancer Research) Tuesday March 1st 2016


181) ESR1 Mutations in Breast Cancer (Clinical Cancer Research) Tuesday March 1st 2016


182) Metformin and Pancreatic Cancer Survival (Clinical Cancer Research) Tuesday March 1st 2016


183) Targeting mTOR Mutations in Melanoma (Clinical Cancer Research) Monday February 15th 2016


184) High-Grade Progression of Neuroendocrine Tumors (Clinical Cancer Research) Monday February 15th 2016


185) Pharmacodynamic Monitoring of Proapoptotic Drugs (Clinical Cancer Research) Monday February 15th 2016


186) ESR1 Mutations Detected in Circulating Tumor DNA (Clinical Cancer Research) Monday February 15th 2016


187) DNA Methylation on Benign Biopsy as a Prostate Cancer Marker (Clinical Cancer Research) Monday February 15th 2016


188) RhoA in Diffuse Gastric Cancer Stem-Like Cells (Clinical Cancer Research) Monday February 15th 2016


189) Image-Guided Interventions of Head and Neck Cancer (Clinical Cancer Research) Monday February 15th 2016


190) Crizotinib and Chemotherapy Synergize in Neuroblastoma (Clinical Cancer Research) Monday February 15th 2016


191) MEK Inhibition Restores Response to ER Blockade in HGSOC (Clinical Cancer Research) Monday February 15th 2016


192) Cabozantinib Inhibition Is Effective against TNBC (Clinical Cancer Research) Monday February 15th 2016


193) Targeted NGS of Cell-Free DNA from Advanced NSCLC (Clinical Cancer Research) Monday February 15th 2016


194) HAGE, a Promising Target in Triple-Negative Breast Cancer (Clinical Cancer Research) Monday February 15th 2016


195) Survival of TNBC Patients in the HIBCRIT-1 Study (Clinical Cancer Research) Monday February 15th 2016


196) Nivolumab in Metastatic Melanoma: irAE Relation to Survival (Clinical Cancer Research) Monday February 15th 2016


View: prev | next


Mitch Andre Garcia's Chem Feeds 2008-present

Some images have been reproduced by permission of The Royal Society of Chemistry. (RSC' RSS Policy)
Other images have been reproduced with permission of the American Chemical Society. (ACS' RSS Policy)
Few images have been reproduced with pending permission of Wiley-VCH. ()